Showing results (521-530 of 834) with videos related to
Sort By:
Pageof 84
Journal of Research in Pharmacy Practice|May 19, 2015
Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicinesPernille Warrer, Peter Bjødstrup Jensen, Lise Aagaard, et al.BMJ Open|October 23, 2025
Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetesMaria Bitsch Poulsen, Tina Okdahl, Jens Hove Buciek, et al.American Heart Journal|May 3, 2005
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney diseaseT-Christian H Mix, Robert M Brenner, Mark E Cooper, et al.International Journal of Cardiology|July 17, 2016
Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and functionPeter G Jørgensen, Magnus T Jensen, Rasmus Mogelvang, et al.The New England Journal of Medicine|August 27, 2021
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 DiabetesBertram Pitt, Gerasimos Filippatos, Rajiv Agarwal, et al.European Heart Journal|January 13, 2022
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysisRajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, et al.Heliyon|January 3, 2023
Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetesJoana Mendes Lopes de Melo, Jens Christian Laursen, Niels Søndergaard-Heinrich, et al.Diabetologia|March 23, 2019
Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, David A D'Alessio, Judith Fradkin, et al.Diabetologia|October 6, 2018
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, David A D'Alessio, Judith Fradkin, et al.Diabetes Care|October 7, 2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, David A D'Alessio, Judith Fradkin, et al.Pageof 84